Skip to Main Content

Paper Details

P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.
Nat Cancer
13
2022
AKT, AML, AML cell lines, AML cells, MLL-AF9, P2RY2, PI3K, Selinexor, XPO1, acute myeloid leukemia, diffuse large B-cell lymphoma, ipatasertib, mouse, patient-derived primary cultures, purinergic receptor P2RY2, relapsed/refractory acute myeloid leukemia, selinexor
Animals, Antineoplastic Combined Chemotherapy Protocols, Exportin 1 Protein, Karyopherins, Leukemia, Myeloid, Acute, Mice, Proto-Oncogene Proteins c-akt, Receptors, Cytoplasmic and Nuclear, Receptors, Purinergic P2Y2, United States
Author NameAffiliation
Kevin H LinDuke University
Justine C RutterDuke University
Abigail XieDuke University
Shane T KillarneyDuke University
Camille VaganayUniversite de Paris, INSERM, CNRS
Chaima BenaksasUniversite de Paris, INSERM, CNRS
Frank LingUniversite de Paris, INSERM, CNRS
Gaetano SodaroUniversite de Paris, INSERM, CNRS
Paul-Arthur MeslinUniversite de Paris, INSERM, CNRS
Christopher F BassilDuke University
Nina FenouilleUniversite de Paris, INSERM, CNRS
Jacob P HojDuke University
Rachel WashartDuke University
Hazel X AngDuke University
Christian Cerda-SmithDuke University
Paul ChaintreuilUniversite Cote d'Azur
Arnaud JacquelUniversite Cote d'Azur
Patrick AubergerUniversite Cote d'Azur
Antoine Forget (CM4AI)Universite de Paris, INSERM, CNRS
Raphael ItzyksonUniversite de Paris, INSERM, CNRS
Min LuDuke University
Jiaxing LinDuke University
Mariaelena PierobonCenter for Applied Proteomics and Molecular Medicine, George Mason University
Zhecheng ShengDuke University
Xinghai LiDuke University
Ashutosh ChilkotiDuke University
Kouros OwzarDuke University
David A RizzieriDuke University Medical Center
Timothy S Pardee
Lina BenajibaUniversite de Paris, INSERM, CNRS
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Emanuel F PetricoinCenter for Applied Proteomics and Molecular Medicine, George Mason University
Alexandre PuissantUniversite de Paris, INSERM, CNRS
Kris C WoodDuke University
  • 1 - 34

Datasets